The deep irony here is that SNT currently aren't exposed to any...

The deep irony here is that SNT currently aren't exposed to any price differentiations across multiple Territories, Regions or Countries... as they are a non revenueing company..

Trumps EO is to align the USA purchase price of drugs to the lowest global offered price.... yeah sure ,, Big Pharma are in the largest single group of political donors in the United States..

I've seen the answers Big Pharma deliver at enquiries in the past and it rounds out pretty simply eg
Pfizer were questioned surrounding the cost of XYZ ?? that put into perspective they have 89,000 employees who's only income is derived from the sale of prescription drugs.. plus Pfizer quoted they invest $3B pa on R and D ,, They have a commitment to SH and Wall St..... boom back to business..

I'm becoming a little frustrated at the lack of Market Messaging from SNT ,, with Phase II Data currently under analysis where is the "Awareness" ?? who's priming the groundwork for the release??? if SNT want to maximise SH returns then they need to establish in the market pace that Data is on its way and the Value of said Data will heavily benefit SH....

My only hope is that the Presentation of the Data is not bridled and the SP this time is aloud to run.... NZT